NEW YORK (GenomeWeb) – Agilent Technologies today said it named Alacris Theranostics an Agilent Certified Service Provider for target enrichment. 

Alacris is based in Berlin and provides molecular analysis and bioinformatics through an approach called ModCell, which is intended to match patients with appropriate therapies. According to Agilent, Alacris exploits next-generation sequencing and other omics data to facilitate drug development and personalized medicine in cancer and other complex diseases. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.